Mayo Clinic researchers from the Center of Regenerative Medicine have utilized a patient’s own stem cells in a novel treatment for heart disease. The treatment involves harvesting the patient’s own stem cells, expanding and differentiating them in-vitro [outside the body] and transplanting them back into the patient. As a result of the successful initial study, a wider clinical trial is planned.
Cardiovascular disease is the leading cause of death worldwide, with 5.8 million cases of heart failure in the United States alone. Stem cell therapy could reduce this number by approaching CVD in a new way. According to Dr. Terzic, the lead researcher in the study, “We are moving from traditional medicine, which addresses the symptoms of the disease, to being legitimately able to cure the disease.”
We believe that this approach represents the emerging gold standard of regenerative medicine – recovering the patient’s own stem, culturing and differentiating them in-vitro and transplanting them back into the patient. The potential applications of this approach will be widespread as researchers continue to advance technologies using stem cells thereby accelerating therapies for many debilitating diseases, trauma and injury. To learn more about the utility of stem cells, how regenerative medicine is shaping the future of medicine, and how you can safely preserve your own valuable stem cells toensure your future health, visit www.StemSave.com or call 877-783-6728 (877-StemSave) today.
To view the full article, click